Identify Gene Functions at late endosome & lysosome interface in yeast

鉴定晚期内体的基因功能

基本信息

项目摘要

DESCRIPTION (provided by applicant): Correct sorting and vesicular trafficking of molecules to the degradative lysosome is an essential feature of all eukaryotic cells. The late endosome is the convergence point of the endocytic pathway and the biosynthetic pathway of trafficking to the lysosome. As such, distinct trafficking events occur at the late endosome as it interfaces with three compartments: TGN, endocytic endosomes, and Iysosomes. Our long term goal is to define the regulatory processes at the late endosome to lysosome interface. The late endosome and vacuole of the yeast Saccharomyces cerevisiae are functionally equivalent to the mammalian late endosome and lysosome; its carboxy peptidase Y (CPY)-pathway of vacuolar delivery parallels the mannose-6-phosphate pathway in mammalian cells. Yeast offers the advantage of both conventional and molecular genetic tools; large majority of yeast genes identified in lysosomal trafficking have orthologues in humans. Using a novel immunodetection screen, we have isolated four mutants that are defective at endosome to vacuole stage of CPY delivery and processing (env mutants). Characterizations of the mutants have established defects in both late endocytic steps and vacuolar structure/function. The first gene of the collection has been cloned; env1 is a unique allele of VPS35 that defines a second role for its conserved gene product. In this proposal, our specific aims are to complete a genomic approach to directly identify additional ENV genes from a yeast deletion library and to clone and molecularly characterize ENV3. Inherent in this AREA proposal, is the aim to continue productive research training of undergraduate and masters students within a comprehensive, Hispanic Serving Institute. Mislocalization of lysosomal proteases and cargo is associated with Lysosomal Storage Diseases and Alzheimer's Disease (AD). Defects specifically at the late endosome to lysosome stage of trafficking have emerged as the possible underlying mechanism in both juvenile and aging neurodegeneration diseases. PUBLIC HEALTH RELEVANCE: The proposed research is relevant to public health issues associated with neurodegeneration of aging as manifested in Alzheimer's Disease. It is also relevant to public health issues associated with the progressive neurodegeneration of juvenile patients with lysosomal storage diseases.
描述(由申请人提供):正确的分子分选和囊泡运输到可降解的溶酶体是所有真核细胞的基本特征。晚期内小体是运输到溶酶体的内吞途径和生物合成途径的交汇点。因此,不同的转运事件发生在内体晚期,因为它与三个隔室对接:TGN、内吞内体和内质体。我们的长期目标是确定晚期内小体到溶酶体界面的调控过程。酿酒酵母的晚期内体和液泡在功能上与哺乳动物晚期内体和溶酶体相同,其空泡递送的羧基肽酶Y(CPY)途径与哺乳动物细胞中的甘露糖-6-磷酸途径平行。酵母提供了传统和分子遗传工具的优势;在溶酶体运输中发现的绝大多数酵母基因在人类中都有同源基因。利用一种新的免疫检测屏幕,我们分离到了四个在cpy递送和加工的内体到液泡阶段有缺陷的突变体(env突变体)。突变体的特征已经确定在内吞的晚期步骤和空泡结构/功能上都存在缺陷。该集合的第一个基因已经被克隆;env1是VPS35的一个独特的等位基因,它定义了其保守基因产物的第二个角色。在这项建议中,我们的具体目标是完成一种基因组方法,直接从酵母缺失文库中鉴定更多的ENV基因,并克隆和鉴定ENV3。这一领域建议的固有目标是在一个综合性的拉美裔服务学院内继续对本科生和硕士学生进行生产性研究培训。溶酶体蛋白水解酶和CARO的错误定位与溶酶体储存疾病和阿尔茨海默病(AD)有关。在幼年期和老年性神经退行性疾病中,缺陷特别是在运输的内小体到溶酶体的晚期阶段已经成为可能的潜在机制。 公共卫生相关性:拟议的研究与阿尔茨海默病中表现的衰老神经退行性变相关的公共卫生问题。它还涉及与患有溶酶体储存性疾病的青少年患者的进行性神经变性有关的公共卫生问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDITTE GHARAKHANIAN其他文献

EDITTE GHARAKHANIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDITTE GHARAKHANIAN', 18)}}的其他基金

Env7 as a Conserved Member of a Novel Kinase Cascade Regulating Membrane Fusion
Env7 作为调节膜融合的新型激酶级联的保守成员
  • 批准号:
    9231468
  • 财政年份:
    2015
  • 资助金额:
    $ 21.53万
  • 项目类别:
Env7 as a Conserved Member of a Novel Kinase Cascade Regulating Membrane Fusion
Env7 作为调节膜融合的新型激酶级联的保守成员
  • 批准号:
    9015461
  • 财政年份:
    2015
  • 资助金额:
    $ 21.53万
  • 项目类别:
Identifying Gene Functions at Late Endosome and Lysosome in Yeast
鉴定酵母晚期内体和溶酶体的基因功能
  • 批准号:
    8165016
  • 财政年份:
    2008
  • 资助金额:
    $ 21.53万
  • 项目类别:
STUDIES ON THE PENTAMERIZATION OF SV40 VP1 IN VITRO
SV40 VP1五聚化的体外研究
  • 批准号:
    6107382
  • 财政年份:
    1997
  • 资助金额:
    $ 21.53万
  • 项目类别:
Bridges to Baccalaureate
通往学士学位的桥梁
  • 批准号:
    9120373
  • 财政年份:
    1994
  • 资助金额:
    $ 21.53万
  • 项目类别:
Bridges to Baccalaureate
通往学士学位的桥梁
  • 批准号:
    9300925
  • 财政年份:
    1994
  • 资助金额:
    $ 21.53万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF THE YEAST VPS10 GENE
酵母 VPS10 基因的分子特征
  • 批准号:
    2187001
  • 财政年份:
    1993
  • 资助金额:
    $ 21.53万
  • 项目类别:
STUDIES ON THE PENTAMERIZATION OF SV40 VP1 IN VITRO
SV40 VP1五聚化的体外研究
  • 批准号:
    3734629
  • 财政年份:
  • 资助金额:
    $ 21.53万
  • 项目类别:
STUDIES ON THE PENTAMERIZATION OF SV40 VP1 IN VITRO
SV40 VP1五聚化的体外研究
  • 批准号:
    5211953
  • 财政年份:
  • 资助金额:
    $ 21.53万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 21.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了